Home > Quotes > NYMX > Press Releases
NYMX

Nymox Pharmaceutical Corporation Press Releases

$5.14
*  
0.01
  negative  
0.19%
Get NYMX Alerts
*Delayed - data as of May 20, 2013 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Nymox Reports First Quarter 2013 Financial Results
05/15/2013 9:45AM - GlobeNewswire

Nymox Reports on Symposium and Panel Discussion on NX-1207 at American Urological Association Annual Meeting
05/06/2013 9:00AM - GlobeNewswire

Nymox Announces Completion of Patient Enrollment in Final Pivotal U.S. Phase 3 BPH Study
05/03/2013 11:47AM - GlobeNewswire

Nymox NX-1207 Symposium May 5 in San Diego at Annual Meeting of American Urological Association at San Diego Convention Center
04/30/2013 11:02AM - GlobeNewswire

Nymox Announces First Patient Enrollment for NX02-0022 Reinjection Study of NX-1207 for BPH
04/23/2013 12:00PM - GlobeNewswire

New Study Supports Favorable Sexual Function Profile for Nymox's NX-1207 for Prostate Enlargement
04/16/2013 10:32AM - GlobeNewswire

Nymox NX-1207 BPH and Prostate Cancer Symposium at American Urological Association Annual Meeting May 5 in San Diego
04/11/2013 9:50AM - GlobeNewswire

Press Release Issued Under the Early Warning System/Sale of Shares of Nymox Pharmaceutical Corporation
04/02/2013 5:00PM - GlobeNewswire

Nymox's NicAlert(TM) Has Achieved Widespread Acceptance in Tobacco-Related Research Studies
03/27/2013 11:00AM - GlobeNewswire

Nymox Prostate Cancer Trial Receives Positive Interim Safety Review From Independent Data Monitoring Committee
03/19/2013 10:00AM - GlobeNewswire

Nymox Announces Presentation of NX-1207 Data at Annual Meeting of the European Association of Urology
03/18/2013 9:31AM - GlobeNewswire

Nymox Announces Upcoming Presentation of NX-1207 Data at European Association of Urology Congress
03/15/2013 11:30AM - GlobeNewswire

Nymox Reports 2012 Financial Results
03/15/2013 9:45AM - GlobeNewswire

Nymox Provides Current Phase 2 Prostate Cancer Clinical Trial Update
03/05/2013 11:19AM - GlobeNewswire

Nymox Says No Material Information or News in Relation to Unusual Market Activity
03/01/2013 1:43PM - GlobeNewswire

Favorable February 18 Safety Monitoring Committee Meeting for Nymox Pivotal Phase 3 NX-1207 Trials
02/21/2013 10:30AM - GlobeNewswire